Smart Orthopedic Implant Platform
Bone healing/fusion in spine and orthopedic surgery
Pre-clinicalActive
Key Facts
Indication
Bone healing/fusion in spine and orthopedic surgery
Phase
Pre-clinical
Status
Active
Company
About DirectSync Surgical
DirectSync Surgical is developing a novel platform for smart, self-powered orthopedic implants that sense load and stimulate bone growth using energy harvested from human motion. Founded in 2019, the San Diego-based company has secured FDA Breakthrough Device Designation and significant non-dilutive NIH SBIR funding, validating its innovative approach. The technology aims to improve surgical outcomes by providing real-time post-operative data to physicians while actively promoting healing, positioning the company at the intersection of medtech and digital health. It is currently in the pre-clinical stage and seeking seed investment to advance its platform.
View full company profile